Search results
Biotech Stocks Facing FDA Decision In May 2024
RTT News· 2 hours agoAs April comes to an end, attention shifts to biotech stocks poised for regulatory events in May. The FDA approved eight novel drugs last May, contributing to a total of 55 ...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 20 hours ago(NYSE: PFE) announced today the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA...progression on or after chemotherapy ...
FDA Approves Second Gene Therapy for Hemophilia B
Medscape· 5 days agoPfizer reported a list price of $3.5 million for its new gene therapy, Beqvez, for adults with this rare bleeding disorder.
On doorstep of approval, Merck compares V116 pneumococcal vaccine to 1983 warhorse Pneumovax 23
FierceBiotech· 1 day agoFive months ago, Merck revealed data that indicate its next-generation pneumococcal vaccine offers more protection for older adults than Pfizer’s market dominator Prevnar ...
Should You Buy Moderna Before May 12?
Motley Fool via Yahoo Finance· 4 days agoThe biotech company aims to bring as many as 15 new products to market over the next five years and has the... and Drug Administration (FDA) is set to...
Anxiety Disorder Treatment Market Towards US$ 15.89 Bn by 2030 | Rising Mental Health Awareness and...
Digital Journal· 4 days agoThe global anxiety disorder treatment market size is projected to grow from $12 billion in 2022 to $...
Pharma Stock Roundup: MRK, SNY, AZN, NVS' Q1 Results, Pipeline & Regulatory Updates
Zacks via Yahoo Finance· 4 days agoFDA Nod for Rare Cancer in Kids: The FDA granted approval to Novartis’ radioligand therapy,...
Why Big Pharma Is Following Novartis' Lead In A $25 Billion Market
Investor's Business Daily· 5 days agoOver the past decade, Big Pharma has spent $15 billion in acquisitions of radiopharmaceuticals...
